Espee Pharma (Uk) Limited
08868139
Healthy
- No accounts filed in last 18 months (-5)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 30/01/2014
DIRECTOR
BRITISH · UNITED KINGDOM · Age 40
Also on 1 other board
director · Since 01/11/2022
CHEMIST
BRITISH · ENGLAND · Age 67
Also on 7 other boards
Persons with Significant Control
Ric Chemicals Limited
Unit 1 Conqueror Court, Spilsby Road, Romford, RM3 8SB
Reg: 03091306 · Companies House · Limited Company
Notified 06/04/2016
Espee Biopharma & Finechem Llc
500, Lake Cook Rd, Deerfield, IL 60015
Reg: 4679062 · Delaware Companies · Trading Company
Notified 06/04/2016
CompanyRankvs 1700+ SIC 47730 peers66
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2024
Turnover
£4.4M
Annual revenue
Net Worth
£300k
Balance sheet strength
Cash
£584k
Cash in the bank
Profit Before Tax
£62k
Bottom line earnings
Net Current Assets
£299k
Working capital
Current Assets
£995k
Current Liabilities
£696k
Fixed Assets
£538
Debtors
£268k
Cost of Sales
£3.8M
Gross Profit
£605k
Admin Expenses
£520k
Operating Profit
£85k
Profit After Tax
£50k
Tax at Year End
Director Loans
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit | Est. Revenue |
|---|---|---|---|
| 2024 | 1.43 | +£50k | £400k |
| 2023 | 3.42 | +£22k | £400k |
| 2022 | 3.57 | +£39k | — |
| 2021 | 4.49 | +£30k | — |
| 2020 | 1.44 | +£26k | — |
| 2019 | 1.42 | +£12k | — |
| 2018 | 1.50 | — | — |
Derived from filed accounts. Not audited figures.